Cobra Biologics Limited, a leading contract development and manufacturing organisation (CDMO), is headquartered in the United Kingdom. Established in 2003, Cobra has made significant strides in the biopharmaceutical industry, specialising in the production of plasmid DNA, viral vectors, and cell line development. With operational facilities in both the UK and Sweden, the company serves a global clientele, providing tailored solutions for gene therapy and vaccine development. Cobra's core offerings include high-quality plasmid DNA and viral vector production, distinguished by their commitment to stringent quality standards and regulatory compliance. The company has achieved notable milestones, including successful collaborations with prominent biotech firms, solidifying its position as a trusted partner in the biomanufacturing landscape. With a focus on innovation and customer-centric services, Cobra Biologics continues to play a pivotal role in advancing biopharmaceutical development.
We don't have data for Cobra Biologics Limited, but we can show you information about their parent organization instead.
View parent company